Topic
SpaceX Research
Current institutional research highlights a market environment that prioritizes private equity and large-scale technological infrastructure, both of which are central to the SpaceX narrative. While Goldman Sachs reports aggressive selling within the Industrials sector, there is a persistent institutional appetite for private markets as diversifiers that offer higher returns and lower volatility than traditional public indices. This focus on private assets is increasingly relevant as BlackRock emphasizes a 'speed and scarcity' theme, particularly regarding the projected $1 trillion annual AI infrastructure buildout. Despite potential headwinds from hawkish Federal Reserve policies and high institutional leverage reaching five-year peaks, there remains a tactical preference for U.S. equities and technology beneficiaries. Additionally, the development of liquid private equity investment vehicles is bridging the gap for retail access to historically illiquid segments of the market. Consequently, the research suggests that while the broader industrial sector faces selling pressure, capital continues to flow toward high-growth, private-market leaders that define the next generation of technological expansion.
4165 reports available
All reports
Page 136 of 168
Trend Micro Profits Miss Consensus but in Line with Guidance
Goldman Sachs · May 14, 2026
India Insights April 2026
Shikhara Investment Management · May 14, 2026
Iran War Strategic Impasse
SEB · May 14, 2026
ETP Flow Update
BlackRock / iShares · May 14, 2026
Morning Report
Westpac Banking Corporation · May 14, 2026
European Rates and Economics Daily
RBC Capital Markets · May 14, 2026
UK and European Research at a Glance
RBC Capital Markets · May 14, 2026
Emerging Market Weekly Pulse
Crédit Agricole Corporate and Investment Bank · May 14, 2026
Cisco Systems Inc F3Q26 Review
Goldman Sachs · May 14, 2026
Middle East Daily
MUFG · May 14, 2026
Americas Retail Sales April Update
Goldman Sachs · May 14, 2026
Tau Data Calls for Further Analysis into Ph3 Start
Goldman Sachs · May 14, 2026
Americas Healthcare Biotechnology 1Q26 EPS Updates
Goldman Sachs · May 14, 2026
Andina Model Update Post Q1
Goldman Sachs · May 14, 2026
Lotes: Material Cost Remains a Near-Term Overhang
Goldman Sachs · May 14, 2026
Merck KGaA Process Solutions De-risked for 2026
Goldman Sachs · May 14, 2026
Equity Client Flow Trends Big Tech Inflows During Sector Rally
Bank of America · May 14, 2026
Sysmex Earnings Review Results In Line
Goldman Sachs · May 14, 2026
Navigate26 Showcases Potential for Multi-Year Market Share Gains
Goldman Sachs · May 14, 2026
nCino nSight 2026 Agentic Operating System and Bank AI Priorities
Goldman Sachs · May 14, 2026
Hedge Fund Monthly Update
Bank of America · May 14, 2026
Out of Tokens: Xi/Trump, Momentum and Markets
Goldman Sachs · May 14, 2026
Nifco Inc. First Take: Results and Guidance Below Expectations
Goldman Sachs · May 14, 2026
Ninebot Management Call: Improving E2W Demand and Growth
Goldman Sachs · May 14, 2026